I just saw the press release from BTG plc confirming the clinical benefit of Varisolve (polidocanol endovenous microfoam) to treat varicose veins. Dr. Rosenberg and Dr. McNeill were part of the clinical investigation team participating in this FDA approved Phase III trial centered in our Frederick, Maryland office. The purpose of the investigation was to find a suitable effective treatment for varicose veins that does not involve thermal ablation or tumescent anesthesia. Currently the Venefit Procedure (VNUS Closure) is the most durable and effective method to treat reflux in the saphenous vein, the common cause of varicose leg veins.
Currently Varisolve is not yet FDA approved for the treatment of varicose veins, as the data just reported at our big national American College of Phlebology meeting will be presented to the FDA soon. As soon as the FDA gives approval, we will be happy to discuss this option with our patients.
Varicose veins commonly lead to symptoms of leg pain, swelling, throbbing, heaviness, and even restless legs. Treatment is focused on eliminating the backpressure in the leg veins, allowing normal flow to be restored.
There are likely to be several competing methods to treat varicose veins, though not all options will be appropriate for each patient. Be sure that you seek advise from a diplomate of the American Board of Phlebology, as doctors with this added competence in venous disease will likely be best informed of the changing landscape in varicose vein care. Dr. Rosenberg and Dr. McNeill, both vascular surgeons with many years of experience, will be glad to answer your questions at any of the Maryland, Virginia or West Virginia offices of Capitol Vein & Laser.